Cargando…
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
PURPOSE: Oxaliplatin is a third-generation platinum compound, and it has no nephrotoxicity and has reduced bone marrow toxicity. Cancer cells that are resistant to cisplatin are sensitive to oxaliplatin. Oxaliplatin is used widely for the treatment of colon cancers. Recently, oxaliplatin was reporte...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Coloproctology
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998014/ https://www.ncbi.nlm.nih.gov/pubmed/21152225 http://dx.doi.org/10.3393/jksc.2010.26.4.246 |